Financial News
Latest News about MRK
Recent news which mentions MRK
3 Top COVID Stocks -- Are They Tricks or Treats?
October 26, 2021
From Motley Fool
Was Atea Pharmaceutical's Flop Predictable?
October 26, 2021
From Motley Fool
Novavax is Now a Riskier Play, but Still One to Keep Your Eye On
October 25, 2021
Tags
Hot Stocks
NASDAQ:NVAX,NYSE:MRK,NASDAQ:MRNA,NASDAQ:OCGN,NASDAQ:VXRT,NYSE:PFE,NYSE:JNJ,NASDAQ:AZN
MRK
From InvestorPlace
Fauci says U.S. on track to start vaccinating kids aged 5 to 11 by November, as FDA advisers prepare to meet on the matter
October 25, 2021
From MarketWatch
Holiday earnings forecasts have been lumps of coal so far, and here come the biggest ones
October 24, 2021
From MarketWatch
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
From Motley Fool
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
October 23, 2021
From Motley Fool
Novavax Is Set to Win on the Increasing Necessity of Booster Shots
October 22, 2021
From InvestorPlace
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
From Benzinga
Here's Why Agenus Stock Is Getting Hammered Today
October 22, 2021
From Motley Fool
From Benzinga
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
From Motley Fool
Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
October 21, 2021
From Benzinga
2 COVID Stocks I'd Consider Instead of Moderna
October 21, 2021
From Motley Fool
PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial
October 21, 2021
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
From Benzinga
It’s Time to Secure Those Profits You Earned from Novavax
October 20, 2021
From InvestorPlace
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
Here's Why Moderna's Growth May Be Just Getting Started
October 20, 2021
From Motley Fool
Why Atea Pharmaceuticals Is Imploding Today
October 19, 2021
From Motley Fool
David v Goliath in The Race to Develop an Oral Therapy for COVID-19
October 19, 2021
From Benzinga
WHO-Led Program Intends To Purchase Oral COVID-19 Antivirals For $10, Including Merck's: Reuters
October 19, 2021
Tickers
MRK
From Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
2 Bargain Stocks You Can Buy Today and Hold Forever
October 18, 2021
From Motley Fool
3 Stocks to Consider if the October Stock Market Sell-Off Worsens
October 17, 2021
From Motley Fool
Here's Why Warren Buffett Isn't Buying Many Stocks Right Now
October 17, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
